SPO Resumes Revenue Generation

NEW YORK, October 16, 2012 /PRNewswire/ --

SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today that initial shipments of a new consumer wellness product have been delivered to US mass-market retailers. The Company is also forecasting an order backlog for deliveries scheduled through 2013.

This exciting new product is a consumer over-the-counter (OTC) pulse oximeter, which can be used for a variety of respiratory and wellness monitoring activities. This is the first time an SPO proprietary product is being marketed to mass-market retailers and affords a significant opportunity for SPO to generate revenues and growth for its retail business. This development is in line with the restructuring of SPO to focus on non-medical consumer applications.

Michael Braunold, Chief Executive Officer of SPO commented: "Our entry into the consumer market to sell products incorporating our proven proprietary technology to mass-market retailers is an important milestone for us - this activity demonstrates the fruits of our labor with the resumption of revenue generation and backlog production orders. We look to expand our product portfolio during 2013 to further build upon the foundations being established for retail sales."

SPO plans to add to its product portfolio and to release (through a strategic market partner) a new and unique consumer wellness time-piece designed to measure overall daily activity level. This wellness watch is especially useful for overweight or obese adults and children. It includes innovative features, such as display functionality as well as being a fashionable time-piece which continuously measures the number of daily activities and calories burned against a recommended goal. Manufacturing and distribution is scheduled to commence early 2013.

A more detailed description of the financial results and financial statements will be contained in the Quarterly Report on Form 10-Q to be filed with the SEC mid-November 2012.  

About SPO

SPO (SPOM) is a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices to capture life-enhancing information within four key markets: medical care; sports and wellness; homecare monitoring and security. Its patented technology uses information gathered from the reflectance of light on the human body, in a noninvasive manner, to monitor key vital signs. The company manufactures its products in addition to licensing its technologies to appropriate client corporations for commercialization and distribution. For more information, visit http://www.spoglobal.com. 

Forward Looking Statements

This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, the continued generation of revenues, profitability, market acceptance of our products and new product applications, timing of new product launches, success of the Company's rebranding program, product performance, size of prospective markets, revenue assessments, marketing strategies, success of our restructured operations and plans, our ability to generate fees or raise capital to support our business operations and plan, the sufficiency and availability of working capital, changes in economic conditions generally and in more specifically, the introduction of competing products, changes in our operating strategy or development plans patent protection for our products and technologies, changes in economic conditions generally and in more specifically, in the markets we operate, changes in technology, legislative or regulatory changes that affect us and the risks and uncertainties discussed under the heading "Risk Factors" in Item 1 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2011. We undertake no obligation to revise or update any forward-looking statement for any reason.

Contact regarding this release:

SPO
[email protected]    
+1-866-991-7766

SOURCE SPO Medical Inc